share_log

Stephens & Co. Reiterates Equal-Weight on OncoCyte, Maintains $4 Price Target

Moomoo 24/7 ·  Apr 17 10:16

Stephens & Co. analyst Mason Carrico reiterates OncoCyte (NASDAQ:OCX) with a Equal-Weight and maintains $4 price target.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment